Salt AI

Salt AI envisions a future where advanced artificial intelligence seamlessly integrates into life sciences and healthcare, enabling organizations to unlock new realms of discovery and operational excellence. Fueled by a passion for enhancing human health, we are creating a unified AI collaboration platform that empowers both technical and non-technical users to innovate with confidence and speed.

Our platform is designed to dissolve barriers between complex AI models and everyday workflows in regulated biomedical environments. By blending visual-first design with full-code capabilities and scalable deployment options, Salt AI enables researchers, clinicians, and enterprises to harness AI transparently and responsibly for transformative impact.

We are driven by the conviction that accessible, contextual AI will accelerate breakthroughs in drug discovery, clinical development, and healthcare operations, creating measurable value for organizations committed to improving patient outcomes and advancing science at scale.

We've been watching Salt AI since their 2023 launch, and honestly? They're tackling one of the trickiest challenges in tech right now. Most AI platforms either cater to coding wizards or complete beginners—but Salt AI figured out how to serve both audiences without compromising either experience.

Their contextual AI platform is specifically built for life sciences and healthcare, which makes sense when you consider the regulatory nightmares these industries face. You can't just throw a generic AI tool at drug discovery and hope for the best.

What Caught Our Attention

The "unpack the black box" approach really stood out to us. In regulated environments like pharmaceuticals, you need to understand exactly how your AI reached its conclusions—it's not enough to get the right answer if you can't explain the process to the FDA.

We're also impressed by their integration capabilities. Supporting 30+ enterprise data sources isn't just a nice-to-have—it's essential when you're dealing with complex research environments where data lives everywhere from legacy databases to cutting-edge lab equipment.

Real-World Impact

The Ellison Medical Institute partnership tells us everything we need to know about Salt AI's credibility. They're using the platform to model thousands of drug compounds and accelerate cancer therapeutics research. That's not a pilot project—that's mission-critical work.

The fact that they can handle both visual workflow editing for researchers and full coding capabilities for data scientists shows they understand how modern biotech teams actually work. It's collaborative, not siloed.

The Money Trail

Their recent $10 million funding round led by Morpheus Ventures caught our eye—especially the $29 million valuation. That's serious money for a company that's barely two years old, suggesting investors see real potential in their life sciences focus.

With CoreWeave as a participant, they've got the AI infrastructure backing to scale when those big pharma clients come knocking. And trust us, they will.